ICU Medical, Inc. - Common Stock (ICUI)

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...

ICU Medical has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $142.98. The stock also fell short of the...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

This infusion therapy specialist reported a notable insider sale as shares continue to lag over the past year.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

ICU Medical’s first quarter results in 2026 were marked by outperformance against Wall Street expectations, with revenue and non-GAAP earnings per share both...

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

ICU Medical (ICUI) Q1 2026 Earnings Transcript

Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 12.3% year on year...

Medical device company ICU Medical (NASDAQ:ICUI) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 11.6% year on year to $530.2 million...

Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results this Thursday after the bell. Here’s what you need to know. ICU Medical beat analy...

ICU Medical has been treading water for the past six months, recording a small return of 2.8% while holding steady at $120.94. Is now the time to buy ICU Med...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at ICU Medical (NASDAQ:ICUI) and...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...

A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.

Medical device company ICU Medical (NASDAQ:ICUI) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 13% year on year to $540.7 million. Its non-GAAP profit of $1.91 per share was 12.8% above analysts’ consensus estimates.

Medical device company ICU Medical (NASDAQ:ICUI) will be reporting earnings this Thursday after the bell. Here’s what to expect.

On February 16, 2026, the mood surrounding Baxter International (NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the healthcare sector, Baxter recently saw its shares plummet by over 16% in a single trading session. This collapse followed a fourth-quarter 2025 earnings report [...]

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.